Papers

Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern finland

^a Research Institute of Public Health University of Kuopio 70211 Kuopio Finland

Correspondence to: Professor Salonen

	Introduction

Top Introduction Patients, methods, and results Comment References

Mild iron deficiency has been hypothesised to reduce risk of heart disease risk,¹ while a high concentration of body iron has been suggested as a risk factor for myocardial infarction.^{1 2} Menstruation in women and voluntary blood donations are the most important causes of blood loss and thus modulators of stores of body iron. We prospectively investigated the association of donating blood with the risk of acute myocardial infarction in a random population sample of middle aged men.

	Patients, methods, and results

Top Introduction Patients, methods, and results Comment References

We investigated the incidence of acute myocardial infarctions in participants in the Kuopio ischaemic heart disease risk factor study.³ During 1984-9 we carried out baseline examinations of 2682 (83%) of the 3235 men aged 42, 48, 54, or 60 whom we had invited. We obtained data on the subjects' donating blood by record linkage to files of the local Red Cross office. We registered and verified all myocardial infarctions, definite or possible, between the baseline examinations and the end of 1992.² The mean follow up time was 5.5 years, and, with multiple infarctions, we considered only the first. We used Cox's proportional hazard's analyses to compare the occurrence of cardiac events in blood donors and in non-donors.

In the 24 months before the baseline examinations 153 (5.7%) of the 2682 participants had donated blood. During follow up, one (0.7%) of the donors experienced an acute myocardial infarction compared with 226 (9.8%) of the 2529 non-donors (P<0.001 for difference). Table 1) shows that, in a multivariate model adjusted for the main coronary risk factors, the blood donors' risk of acute myocardial infarction was 86% less than that of the non-donors (relative risk 0.14, 95% confidence interval 0.02 to 0.97, P=0.047). Additional adjustment for a large number of measurements of medical history, health state, health practices, and psychosocial characteristics attenuated this association only marginally.

	Comment

Top Introduction Patients, methods, and results Comment References

This is the first study to report a reduced risk of coronary events in male blood donors. The mechanism through which donating blood reduces the risk of coronary events could be the depletion of body iron stores. Such depletion could decrease the amount of injury promoting iron in the myocardium, alter the activity of iron dependent enzymes, increase plasma antioxidative capacity, and decrease lipid peroxidation in both the circulation and in vessel walls.^{1 2 4 5} There is experimental, clinical, and epidemiological support for high iron stores increasing the risk of coronary events and atherosclerotic progression.^{4 5} The lack of consistency in epidemiological studies is probably explained by large variability in estimates of iron stores and iron intake and by the diversity of study outcomes.⁵

We suggest that the loss of iron associated with giving blood might be the reason for the observed risk reduction. However, voluntary blood donors seem to be generally more health conscious and more healthy than those who do not donate blood, and this may have caused self selection bias. In our study the association between donating blood and reduced risk for myocardial infarction was weakened but remained significant after adjustment for the main coronary risk factors. Our finding needs to be confirmed in other prospective population studies, and investigation of the impact of iron depletion on atherosclerotic progression or coronary events is necessary to test the above theory.

	Acknowledgements

We thank Kimmo Ronkainen for carrying out the data analyses and Professor Jaakko Tuomilehto for providing the FINMONICA AMI registry data.

Funding: The study was supported by the Academy of Finland and the Ministry of Education of Finland.

Conflict of interest: None.

	References

Top Introduction Patients, methods, and results Comment References

1. Sullivan JL. The iron paradigm of ischaemic heart disease. Am Heart J 1989;117:1177-88. [Medline]
2. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
3. Salonen JT. Is there a continuing need for longitudinal epidemiologic research?–the Kuopio ischaemic heart disease risk factor study. Ann Clin Res 1988;20:46-50. [Medline]
4. Salonen JT. The role of iron as a cardiovascular risk factor. Curr Opin Lipidology 1993;4:277-82.
5. Salonen JT. Body iron stores, lipid peroxidation and coronary heart disease. In: Hallberg L, Asp N-G, eds. Iron nutrition in health and disease. London: John Libbey, 1996: 293-301.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Blood donation, body iron stores, and risk of myocardial infarction

Harri Hemilä, Mikko Paunio, Tomi-Pekka Tuomainen, Riitta Salonen, Kristiina Nyyssönen, and Jukka T Salonen
BMJ 1997 314: 1830. [Extract] [Full Text]

This article has been cited by other articles:

• Edgren, G., Nyren, O., Melbye, M. (2008). Cancer as a Ferrotoxic Disease: Are We Getting Hard Stainless Evidence?. JNCI J Natl Cancer Inst 0: djn225v1-977 [Full text]  
• Edgren, G., Reilly, M., Hjalgrim, H., Tran, T. N., Rostgaard, K., Adami, J., Titlestad, K., Shanwell, A., Melbye, M., Nyren, O. (2008). Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors. JNCI J Natl Cancer Inst 100: 572-579 [Abstract] [Full text]  
• Zheng, H., Cable, R., Spencer, B., Votto, N., Katz, S. D. (2005). Iron Stores and Vascular Function in Voluntary Blood Donors. Arterioscler. Thromb. Vasc. Bio. 25: 1577-1583 [Abstract] [Full text]  
• Kartikasari, A. E.R., Georgiou, N. A., Visseren, F. L.J., van Kats-Renaud, H., van Asbeck, B. S., Marx, J. J.M. (2004). Intracellular Labile Iron Modulates Adhesion of Human Monocytes to Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 24: 2257-2262 [Abstract] [Full text]  
• Alpert, P. T. (2004). New and Emerging Theories of Cardiovascular Disease: Infection and Elevated Iron. Biol Res Nurs 6: 3-10 [Abstract]  
• Alpert, P. T. (2004). New and Emerging Theories of Cardiovascular Disease: Response to Commentaries. Biol Res Nurs 6: 21-23  
• Gunn, I R, Maxwell, F K, Gaffney, D, McMahon, A D, Packard, C J (2004). Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy. Heart 90: 304-306 [Abstract] [Full text]  
• Ramakrishna, G., Rooke, T. W, Cooper, L. T (2003). Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med 8: 203-210 [Abstract]  
• Surber, R, Sigusch, H H, Kuehnert, H, Figulla, H R (2003). Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography. J. Med. Genet. 40: e58-58 [Full text]  
• Derstine, J. L, Murray-Kolb, L. E, Yu-Poth, S., Hargrove, R. L, Kris-Etherton, P. M, Beard, J. L (2003). Iron status in association with cardiovascular disease risk in 3 controlled feeding studies. Am. J. Clin. Nutr. 77: 56-62 [Abstract] [Full text]  
• Gaenzer, H., Marschang, P., Sturm, W., Neumayr, G.u., Vogel, W., Patsch, J., Weiss, G.u. (2002). Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 40: 2189-2194 [Abstract] [Full text]  
• Haidari, M., Javadi, E., Sanati, A., Hajilooi, M., Ghanbili, J. (2001). Association of Increased Ferritin with Premature Coronary Stenosis in Men. Clin. Chem. 47: 1666-1672 [Abstract] [Full text]  
• Fowler, P.B.S. (2000). The thyroid, blood flow and atheroma. QJM 93: 477-485 [Full text]  
• Sullivan, J. L (2000). Correspondence: The iron hypothesis: claim vs. hypothesis. Vasc Med 5: 127-128  
• Sullivan, J. L. (1999). Iron and the Genetics of Cardiovascular Disease. Circulation 100: 1260-1263 [Full text]  
• Tuomainen, T.-P., Kontula, K., Nyyssonen, K., Lakka, T. A., Helio, T., Salonen, J. T. (1999). Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation : A Prospective Cohort Study in Men in Eastern Finland. Circulation 100: 1274-1279 [Abstract] [Full text]  
• de Valk, B., Marx, J. J. M. (1999). Iron, Atherosclerosis, and Ischemic Heart Disease. Arch Intern Med 159: 1542-1548 [Abstract] [Full text]  
• Klipstein-Grobusch, K., Koster, J. F, Grobbee, D. E, Lindemans, J., Boeing, H., Hofman, A., Witteman, J. C. (1999). Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69: 1231-1236 [Abstract] [Full text]  
• Pan, C. X., Boal, J., for the Geriatrics Journal Club, , Banks, E., Beral, V., Ong, P. J. L., Sorensen, M. B., Hayward, C. S., Webb, C. M., Collins, P., Sullivan, J. L., Heckbert, S. R., Weiss, N. S., Psaty, B. M., Vandenbroucke, J. P., Hulley, S., Grady, D., Vittinghoff, E., Bush, T., Furberg, C., Herrington, D., Riggs, B., Petitti, D. B. (1999). Hormone Replacement Therapy for Secondary Prevention of Coronary Heart Disease. JAMA 281: 794-797 [Full text]  
• Oberle, S., Polte, T., Abate, A., Podhaisky, H.-P., Schroder, H. (1998). Aspirin Increases Ferritin Synthesis in Endothelial Cells : A Novel Antioxidant Pathway. Circ. Res. 82: 1016-1020 [Abstract] [Full text]  
• Tuomainen, T.-P., Punnonen, K., Nyyssonen, K., Salonen, J. T. (1998). Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men. Circulation 97: 1461-1466 [Abstract] [Full text]  
• (1997). . . . and Blood Donation Reduces Risk of MI. Journal Watch Cardiology 1997: 2-2 [Full text]